Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Reome who wrote (807)	4/1/1998 12:18:00 AM
From: John R Resseger	Respond to of 1476

Hi Jim NUMBER OF SHARES OF COMMON STOCK PERCENTAGE NAME AND ADDRESS(1) BENEFICIALLY OWNED(2) OF CLASS(2) ---------------- ------------------------ ----------- SmithKline Beecham Biologicals Manufacturing s.a. 7,732,276(3) 25.84% Rue de L'Institut 89 B-1330 Rixensart Belgium Ruki Renov 2,191,472(4) 8.99% c/o D. H. Blair & Co., Inc. 44 Wall Street New York, N.Y. 10005 Ester Stahler 2,191,472(4) 8.99% c/o D. H. Blair & Co., Inc. 44 Wall Street New York, N.Y. 10005 V. M. Esposito, Ph.D. 2,443,435(5)(6)(7) 9.94% Charles J. Coulter 70,309(8) * Bruce E. Elmblad 52,234(8) * Donald G. Stark 106,024(9) * Gregory C. Zakarian 555,834(10) 2.44% Theresa M. Stevens 80,833(8) * Page 2 of 11 All directors and executive officers (7 persons in group) 3,308,669(11) 13.02% ---------- * less than 1% Who is Ruki and Ester